IB
Immfinity's technology platform utilizes advanced algorithms to identify and optimize therapeutic T-cell receptors, significantly reducing the risks associated with their development. This approach accelerates the creation of targeted immunotherapies for cancer treatment, addressing the lengthy and uncertain process of T-cell receptor engineering.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Immfinity's technology platform utilizes advanced algorithms to identify and optimize therapeutic T-cell receptors, significantly reducing the risks associated with their development. This approach accelerates the creation of targeted immunotherapies for cancer treatment, addressing the lengthy and uncertain process of T-cell receptor engineering.